Banjade Prakash, Subedi Ashish, Acharya Sampada, Itani Asmita, Sharma Munish, Kassam Nadeem, Ghamande Shekhar, Surani Salim
Department of Medicine, Manipal College of Medical Sciences, Pokhara, 33700, Nepal.
Department of Medicine, Gandaki Medical College, Pokhara, 33700, Nepal.
Open Respir Med J. 2024 Jun 4;18:e18743064288565. doi: 10.2174/0118743064288565240515115239. eCollection 2024.
Pulmonary hypertension (PH) is an intricate medical issue resulting from increased pressure in the pulmonary artery (PA). The current gold standard for diagnosis involves an invasive procedure known as right heart catheterization. Nevertheless, cardiac magnetic resonance imaging (cMRI) offers a non-invasive and valuable alternative for evaluating the function, structure, and blood flow through the pulmonary artery (PA) in both the left ventricle (LV) and right ventricle (RV). Additionally, cMRI can be a good tool for predicting mortality by assessing various hemodynamic parameters. We perceive that cMRI may be an underutilized tool in the evaluation of PH. More discussions might be needed to highlight its utility in patients with PH. This article aims to discuss the potential role of cMRI in evaluating PH based on the review of recent literature.
肺动脉高压（PH）是一种由肺动脉（PA）压力升高引起的复杂医学问题。目前的诊断金标准是一种称为右心导管插入术的侵入性操作。然而，心脏磁共振成像（cMRI）为评估左心室（LV）和右心室（RV）中肺动脉（PA）的功能、结构和血流提供了一种非侵入性且有价值的替代方法。此外，cMRI通过评估各种血流动力学参数，可能是预测死亡率的良好工具。我们认为cMRI在肺动脉高压评估中可能是一种未充分利用的工具。可能需要更多讨论来突出其在肺动脉高压患者中的效用。本文旨在基于对近期文献的综述，讨论cMRI在评估肺动脉高压中的潜在作用。
